Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort study
Sign Up to like & getrecommendations! Published in 2019 at "Cardiovascular Diabetology"
DOI: 10.1186/s12933-019-0835-z
Abstract: BackgroundTo determine the impact of dipeptidyl peptidase-4 inhibitor (DPP4i) on the risk of major cardiocerebrovascular and renal outcomes compared with sulfonylurea (SU) combined with metformin in patients with type 2 diabetes from a population-based cohort.MethodsFrom… read more here.
Keywords: peptidase inhibitor; compared sulfonylurea; renal outcomes; cohort ... See more keywords